CCL18 expression in GBM tumors was statistically significantly higher in women (p < 0.05) in both the enhancing tumor region and the tumor core relative to the peritumoral area, but otherwise did not differ between the genders (Figure 2). The gene discussed is CCL18; the disease is neoplasm.